Search for: "Mylan LLC" Results 101 - 120 of 266
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Justice Department announces $3.7 billion in recoveries for FY 2017
26 Dec 2017, 7:08 pm by Ben Vernia
  Mylan paid approximately $231.7 million to the federal government and $213.9 million to state Medicaid programs. [read post]
False Claims Counsel - http://www.falseclaimscounsel.com/wordpress
Patent Trial and Appeal Board Amicus Briefs on Tribal Immunity Issue
5 Dec 2017, 7:40 am by Sarah M Donnelly
Here are the amici curiae in the matter of Mylan Pharmaceuticals Inc. et al v. [read post]
Turtle Talk - http://turtletalk.wordpress.com/
Chief Judge Stark Denies Mylan Defendants’ Motion to Dismiss or Transfer for Improper Venue Subject to Right to Renew After Venue-Related Discovery
1 Dec 2017, 2:53 pm by Gregory B. Williams
Brands LLC, 137 S. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
CAFC affirms D. Del. in Sanofi v. Watson related to generic Multaq®
11 Nov 2017, 11:00 am by Lawrence B. Ebert
Mylan Institutional LLC, 846 F.3d1213, 1221–23 (Fed. [read post]
IPBiz - http://ipbiz.blogspot.com/
Views on Venue -- Take Two: Did the District of Delaware Get It Right?
24 Sep 2017, 9:21 pm by Patent Docs
Mylan because the first prong was no longer applicable in view of the Supreme Court's TC Heartland LLC v. [read post]
Patent Docs - http://www.patentdocs.org/
What are “Acts of Infringement” and Where is “A Regular and Established Place of Business” for a Hatch-Waxman Defendant: The District of Delaware Weighs in on the Patent Venue Rule
20 Sep 2017, 9:18 am by Christine A. Gaddis
We previously reported on the Supreme Court’s decision in TC Heartland LLC v. [read post]
IP Law Alert - http://www.iplawalert.com
D. Delaware addresses Heartland venue issue in case involving BMS' Eliquis®
11 Sep 2017, 5:35 pm by Lawrence B. Ebert
Kraft Food Group Brands LLC, 137 S. [read post]
IPBiz - http://ipbiz.blogspot.com/
Mylan pays $465 million to settle Epi-Pen whistleblower suit brought by a competitor
5 Sep 2017, 7:45 am by Ben Vernia
Mylan Inc. and Mylan Specialty L.P. are both wholly owned subsidiaries of Mylan N.V., which is headquartered in Canonsburg, Pennsylvania. [read post]
False Claims Counsel - http://www.falseclaimscounsel.com/wordpress
Pharmaceutical Companies Agree to Pay $465 Million Settlement in EpiPen False Claims Act Lawsuit
25 Aug 2017, 7:02 am by Fraud Fighters
” The allegations against Mylan were brought to court by pharmaceutical manufacturer Sanofi-Aventis US LLC under a provision of the False Claims Act that permits private qui tam whistleblowers to sue alleged wrongdoers on behalf of the federal government. [read post]
Tycko & Zavareei LLP Blog - http://www.fraudfighters.net/news/
Pharmaceutical Companies Agree to Pay $465 Million Settlement in EpiPen False Claims Act Lawsuit
25 Aug 2017, 7:02 am by Fraud Fighters
” The allegations against Mylan were brought to court by pharmaceutical manufacturer Sanofi-Aventis US LLC under a provision of the False Claims Act that permits private qui tam whistleblowers to sue alleged wrongdoers on behalf of the federal government. [read post]
Tycko & Zavareei LLP Blog - http://www.fraudfighters.net/news/
$465 Million Settlement in Our Client’s Qui Tam Whistleblower Case Over Pharmaceutical Manufacturer’s Underpaying Medicaid Rebates for New EpiPen Products
18 Aug 2017, 2:15 pm by Michael Sullivan
Mylan Inc., et al.. [read post]
Whistleblower Lawyer Blog - http://www.whistleblowerlawyerblog.com/
$465 Million Settlement in Our Client’s Qui Tam Whistleblower Case Over Pharmaceutical Manufacturer’s Underpaying Medicaid Rebates for New EpiPen Products
18 Aug 2017, 2:15 pm by Finch McCranie, LLP
Mylan Inc., et al.. [read post]
Whistleblower Lawyer Blog - http://www.whistleblowerlawyerblog.com/
$465 Million Settlement in Our Client’s Qui Tam Whistleblower Case Over Pharmaceutical Manufacturer’s Underpaying Medicaid Rebates for New EpiPen Products
18 Aug 2017, 2:15 pm by Michael Sullivan
Mylan Inc., et al.. [read post]
Whistleblower Lawyer Blog - http://www.whistleblowerlawyerblog.com/
Mylan’s Preliminary Injunction Against Aurobindo Affirmed
26 May 2017, 6:15 am by Joseph Robinson
The Eastern District of Texas granted a preliminary injunction against Aurobindo in favor of Mylan in the case of Mylan Institutional LLC v. [read post]
IPWatchdog - http://www.ipwatchdog.com/
Mylan Institutional LLC v. Aurobindo Pharma Ltd. (Fed. Cir. 2017)
25 May 2017, 9:59 pm by Patent Docs
By Kevin E. [read post]
Patent Docs - http://www.patentdocs.org/
The CAFC works through a chemical doctrine of equivalents case in Mylan v. Aurobindo
21 May 2017, 5:39 pm by Lawrence B. Ebert
,and Auromedics Pharma LLC (together, “Aurobindo”)appeal from a decision of the United States District Courtfor the Eastern District of Texas granting Mylan InstitutionalLLC’s (“Mylan Inst. [read post]
IPBiz - http://ipbiz.blogspot.com/
More on The Medicines Company v. Mylan, 2017 U.S. App. LEXIS 5947. Reverse doctrine of equivalents?
18 Apr 2017, 6:52 am by Lawrence B. Ebert
Dow AgroSciences LLC, 728 F.3d 1324, 1330-31 (Fed. [read post]
IPBiz - http://ipbiz.blogspot.com/
CAFC in Medicines v. Mylan. Claim term limited to the sole portion of the specification that adequately discloses term
6 Apr 2017, 1:35 pm by Lawrence B. Ebert
Mylan, Inc., No. 15-1113(Fed. [read post]
IPBiz - http://ipbiz.blogspot.com/
Supreme Court Update: Are Secondary Indicia of Invention Relevant to Eligibility?
8 Feb 2017, 3:09 am by Dennis Crouch
Alfonso Cioffi, No. 16-200 (holding prosecution history against the patentee) Civil Procedure – Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
Patently-O - http://patentlyo.com/patent
Cumberland Pharmaceuticals Inc. v. Mylan Institutional LLC (Fed. Cir. 2017)
31 Jan 2017, 8:55 pm by Patent Docs
Mylan Institutional LLC. [read post]
Patent Docs - http://www.patentdocs.org/